100 项与 Abbott Healthcare Products Ltd. 相关的临床结果
0 项与 Abbott Healthcare Products Ltd. 相关的专利（医药）
2002-10-01·Hospital Medicine
Further reduction in mortality following myocardial infarction
Review
作者: Abhyankar, Brihad
Omacor is a new omega-3 fatty acid product that is licensed for secondary prevention post-myocardial infarction. It confers an additional 20% reduction in all-cause mortality, based on the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico prevenzione (GISSI-P) study data. The GISSI-P results are compared with other trials of secondary prevention.
100 项与 Abbott Healthcare Products Ltd. 相关的药物交易
100 项与 Abbott Healthcare Products Ltd. 相关的转化医学
